Category: Medical

The Vein and Laser Center of New Jersey Earns Vein Center Accreditation by IAC

More than one half of Americans age 50 and older are affected by varicose veins. Varicose veins occur when the valves in the leg veins no longer function, causing blood to pool in the legs. In some cases, this condition progresses to a more serious for of venous disease called chronic venous insufficiency (CVI). Whether to relieve symptoms and/pr improve appearance, treating varicose veins can be performed by vein centers that specialize in the evaluation and management of superficial venous disorders.

There are many factors that contribute to an accurate vein treatment and management. The training and experience of the vein specialist performing the procedure, the type of equipment used and the quality assessment metrics each facility is required to measure, all contribute to a positive patient outcome. IAC accreditation is a “seal of approval” that patients can rely on as an indicator of consistent quality care and a dedication to continuous improvement.

The Vein and Laser Center of New Jersey Located in Hamburg, NJ has been granted accreditation by the Intersocietal Accreditation Commission (IAC) in Vein Center in the area of Superficial Venous Treatment and Management.

Accreditation by IAC indicated that The Vein and Laser Center of New Jersey of New Jersey has undergone an intensive application and review process and is found to be in compliance with the published Standards, thus demonstrating a commitment to quality patient care in vein treatment and management. Comprised of a detailed self-evaluation followed by a thorough review by a panel of medical experts, the IAC accreditation process enables both the critical operational and technical components of the applicant facility to be assessed, including representative case studies and their corresponding final reports.

About IAC

IAC provides accreditation programs for vascular testing, echocardiography, nuclear/PET, MRI, diagnostic CT, dental CT, carotid stenting, vein treatment and management and cardiac electrophysiology. The IAC programs for accreditation are dedicated to ensuring quality patient care and promoting health care and all support one common mission: Improving health care through accreditation. IAC accreditation is widely respected within the medical community, as illustrated by the support of the national medical societies related to venous disorders, which include physicians, physician extenders, nurses, and ultrasound technologists. To date, the IAC accrediting divisions have granted accreditation to more than 14,000 sites throughout the United States, Canada, and Puerto Rico.

The Vein and Laser Center of New Jersey is one of only two accredited IAC facilities in New Jersey and the only one in Northern New Jersey. Our office is also IAC accredited in Vascular Testing. Congratulations!

Covidien Announces Five-Year Results from the ClosureFast™

Covidien Announces Five-Year Results from the ClosureFast™ Long-Term European Multi-Center Study in Patients with Lower Limb Venous Disease

Study Demonstrates Long-Term Durability of the ClosureFast™ Radiofrequency Ablation System for Treatment of Chronic Venous Insufficiency

MANSFIELD, Mass.–(BUSINESS WIRE)–Covidien (NYSE:COV), a leading global provider of healthcare products, today announced the five-year results of the ClosureFast™ Long-Term European Multi-Center Study in patients with Chronic Venous Insufficiency (CVI). This study evaluates the five-year outcomes of a minimally invasive endovascular therapy for treatment of CVI.

The ClosureFast Study was conducted prospectively at eight centers in Europe. The Venefit™ procedure (using the ClosureFast radiofrequency ablation catheter) was used to treat 295 lower limbs in 225 patients diagnosed with superficial venous reflux, the underlying cause of varicose veins and CVI. This progressive medical condition affects the veins in the leg and compromises their ability to carry blood back to the heart. This is a worldwide issue and, in fact, impacts over 30 million Americans in the United States alone.1 If left untreated, varicose veins can advance to CVI, which, in severe cases, may result in lower leg pain, skin damage, and leg ulcerations.

“The five-year final analysis from the ClosureFast Study shows sustained treatment success in anatomical and clinical categories and supports its leading position in endovenous vein treatment,” said Thomas Proebstle, MD, Universitaets Hautklinik Heidelberg, Germany, who recently delivered the study results at the American College of Phlebology 26th Annual Congress.

ClosureFast Study Design and Five-Year Results

This prospective, multi-center study enrolled 225 patients and treated 295 limbs at eight centers in Europe from April 2006 to June 2007. The study treated patients diagnosed with superficial venous reflux with the minimally invasive Venefit procedure using the ClosureFast radiofrequency ablation catheter.

Patients were evaluated following the procedure by duplex ultrasound imaging and clinical examination at three days, three months, six months and in yearly intervals up to five years. Of the 295 treated limbs, 233 (79%) were available for examination at five years. According to Kaplan-Meier analysis, at five-year follow-up, full occlusion of the treated vein was observed in 92% of patients (vs. 98% at one year). The vast majority (95%) of patients were free of pathological venous reflux (vs. 99% at one year). This demonstrates durable results of the Venefit™ procedure out to five years.

The average Venous Clinical Severity Score (a multifactorial score measuring disease severity and quality of life) improved from 3.9 ± 2.1 before treatment to 1.3 ± 1.7 at 5 years. In addition, only 14% of limbs were CEAP (disease severity classification) class 3 or higher at 5 years, while, at baseline, 48% of limbs were in the same category.

“This pivotal study provides substantial long-term data on relevant end-points to help clinicians decide the appropriate treatment for their patients, thus defining Covidien’s commitment to a strong foundation of clinical research,” said Mark A. Turco, MD, Chief Medical Officer, Vascular Therapies, Covidien.

About CVI and the Venefit Procedure

CVI, or Chronic Venous Insufficiency, is a progressive, sometimes debilitating medical condition. It occurs when valves in the veins of the lower leg no longer function to push blood back to the heart. This allows blood to flow backward, or reflux resulting in enlarged, or varicose, veins. If left untreated, the condition can progress, and, in severe cases, can result in lifestyle-limiting lower leg pain, skin damage and ulcerations. Traditional surgical treatments that close or remove the diseased veins, including vein stripping, may be painful and can result in long recovery times for patients.ii

Alternatively, patients can be treated with a minimally invasive endovascular procedure such as the Venefit procedure. During the Venefit procedure, the ClosureFast catheter is inserted into the diseased vein and radiofrequency energy is used to seal the vein shut. Blood that would normally return to the heart through the diseased vein travels back through other veins instead. Over time, the treated vein shrinks and is absorbed by the body. Compared with surgical options, minimally invasive ablation of the vein can result in less pain and quicker recovery time.ii

About Covidien

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2012 revenue of $11.9 billion, Covidien has 43,000 employees worldwide in 70 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business.

1 Gloviczki P, et al. The care of patients with varicose veins and associated chronic diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. JVS; May 2011. ii L. H. Rasmussen, M. Lawaetz, L. Bjoern, B. Vennits, A. Blemings, and B. Eklof, Randomized Clinical Trial Comparing Endovenous Laser Ablation, Radiofrequency Ablation, Foam Sclerotherapy and Surgical Stripping for Great Saphenous Varicose Veins. British Journal of Surgery Society Ltd, Wiley Online Library, www.bjs.co.uk, March 15, 2011.

View A Miracle App Offers Moms Sharable Gender Reveal

NJ based 3D and 4D ultrasound imaging company makes it easier to show off child in womb; makes social gender reveal easy to share.

(Newswire.net — January 20, 2015) North Brunswick , New Jersey — View A Miracle, a New Jersey 3D and 4D ultrasound imaging company, has launched an app for expectant mothers seeking gender reveals, 4D ultrasounds and memorable moments of their child while in utero. The app was created as a convenience for customers to be able to share their baby’s sonograms and milestones throughout the pregnancy. It also delivers a rewards program.

The unique app taps into the growing trend of expectant parents who are excited to share ultrasound pictures with friends and extended family.  Since the introduction of ultrasound technology, expectant parents have been finding new ways to share these amazing and precious photos. Recent trends include sharing sonograms on family holiday cards, attached in emails and posted on social media.

The View A Miracle App makes sharing much easier across digital platforms such as the internet, smart phones, Facebook, Twitter and other social media platforms; it was designed to provide mobile convenience for their existing and prospective customers.

With the average American never leaving home without their phone, and now spending upwards of 2 hours per day on mobile devices, phones are always within reach. View A Miracle was interested in harnessing the technology to deliver added value benefits to expecting mothers making it easier for them to participate in the loyalty program, specials, giveaways, online booking and payments, as well as be notified of special events and general information.

“This app is one of a few of its kind for this industry. We know our clients will appreciate the convenience and the reward savings for their continued patronage,” Kayla Gipson, RDMS, Owner of View A Miracle.

The app is available for download on iTunes and on GooglePlay .

View A Miracle is a 3D and 4D ultrasound imaging company based in North Brunswick, NJ that serves the New York, New Jersey, Pennsylvania and Delaware expectant parents. For more information please call (732) 422-7022 or visit www.viewamiracle.com

View A Miracle

1626 US RT 130
North Brunswick , New Jersey United States 08902

732 422-7022
 
http://www.viewamiracle.com

Northern Virginia’s Premier Prenatal Ultrasound Imaging Provider Expands Practice to Offer Medical Thermography

Medical Thermal Imaging Gaining Popularity for Ability to Detect Some Cancers and Diseases in Very Early Stages

(Fairfax, VA) – InfantSee4D – Northern Virginia’s premier prenatal ultrasound imaging

provider – recently announced the addition of medical thermography to their esteemed practice. Thermography Imaging, Inc. now offers this painless, safe, non-invasive and popular procedure which uses a thermal imaging camera to detect heat and inflammation within the body. Designed to be a complement to other forms of diagnostic testing such as mammograms, MRIs and CT scans, thermography often detects problems and areas of concern in very early stages.

According to Thermography Imaging, Inc. owner and founder Maria Christopoulos, many illnesses can be difficult to detect until it is too late. This was the case for Christopoulos herself who was diagnosed with a brain tumor several years ago.

“My own illness inspired me to seek alternative ways of detecting issues in the human body,” explains Christopoulos. “Medical thermography can be used to identify potential problem areas before they manifest. We encourage our clients to share their scans with their personal physicians. Early detection of any disease can result in a more optimistic prognosis.”

Christopoulos says that anyone at any age can benefit from medical thermography. She recommends first time clients consider a full body “baseline” scan, which provides a comprehensive view of their entire body that can be used later for comparison.

“Many people ask us to perform an initial full body thermal imaging scan, then have the scan repeated annually to identify potential problem areas,” says Christopoulos.

One particular area of interest for women is breast scans. Christopoulos says mammograms normally detect cancer after the mass becomes large enough to be felt or seen. Thermography, however, allows for the budding cells to be seen. In many cases, thermography can see changes in the breast much earlier.

“The roads must be built before the city can be formed,” explains Christopoulos.

Christopoulos says thermography is popular for younger clients who have not reached the age to begin regular mammogram screenings, yet would like to see if they have any underlying areas of concern. Women who get regular mammograms are encouraged to continue doing so based on their doctor’s recommendations.  Adding thermography to annual mammogram screenings can help detect cancers at the earliest possible stages.

“Our personal goal and vested interest is to make sure that our technology makes a difference in the lives of the families we serve,” explains Christopoulos. “As Benjamin Franklin said, ‘an ounce of prevention is worth a pound of cure’. Early clinical diagnosis not only allows you to begin healing sooner, it can literally save your life.”

Interested in learning more?  Visit thermographyimaging.com. Mention this article and receive 25% off your first scan.

About Thermography Imaging, Inc.

Thermography Imaging, Inc. is a premier provider of medical thermography, also known as medical thermal imaging and digital infrared thermal imaging (DITI). This painless, safe, non-invasive procedure uses a thermal imaging camera to detect heat and inflammation within the body. In many cases, problems and areas of concern can be detected in very early stages. Thermography is designed to be a complement to other forms of diagnostic testing such as mammograms, MRIs and CT scans. Thermography Imaging, Inc. uses the Meditherm med 2000™ which features medical grade sensitivity to deliver high quality thermography scans and can operate in the narrowest of temperature ranges.  Founder and owner Maria Christopoulos is a Board Certified Medical Thermographer in DITI. She completed advanced clinical medical thermography training at the American College of Clinical Thermography.  Christopoulos earned her Bachelor’s degree from the University of Maryland’s College of Behavioral and Social Sciences and has spent over a decade in the field of imaging and working with women and children. For more information, visit thermographyimaging.com.

 

Prenatal Peek® Announces the Grand Opening of their New West Covina, California Location

Starting on Sunday, April 17, 2016, expectant parents in West Covina, California and surrounding cities (Los Angeles, La Puente, West Covina, Baldwin Park, Irwindale, El Monte, Walnut, Valinda, Azusa, Avocado Heights, South Hills, City Industry) can visit Prenatal Peek® at their new location: 841 Glendora Ave, West Covina. Prenatal Peek® will have lots of specials and celebrations planned, so if you have been considering 3D/4D Ultrasound, now is the time to visit Prenatal Peek®!

Go to: http://prenatalpeek.com

HealthWorks Launches New Website

TheSiteCrew.com is pleased to announce the launch of a new website for HealthWorks in Summerville, South Carolina at www.healthworksmed.com

This new website, with its responsive design and clean modern look, better meets the needs of the rapidly growing number of consumers using smartphones, tablets, iPads, and other devices to go online.

Website features:

  • Simple, clear navigation located at both the top and bottom of every web page
  • Slideshow on the home page highlighting the primary services offered
  • Quick overview of the company and its services on the home page
  • Detailed information about the company and the services offered
  • Email contact form and contact information located on every web page
  • News blog including an RSS subscription feed
  • Responsive design to provide an optimal viewing experience—easy reading and navigation with a minimum of resizing, panning, and scrolling—across a wide range of devices (from mobile phones to desktop computer monitors)
  • Social media links and sharing interface within each page of website

Surgical Specialists of Ocala Proudly Welcomes Board Certified Vascular Surgeon Dr. Purandath Lall to Our Practice

Surgical Specialists of Ocala
1920 SW 20th Place, #100
Ocala, FL 34471
352-237-1212
website:  http://surgicalspecialistsocala.com

We are excited to announce the addition of board certified vascular surgeon Dr. Purandath Lall, MBBS, FRCS (Ed), FACS, RPVI, to our practice. Dr. Lall comes to us with quite an impressive background in the field of vascular surgery. He has worked both in the United States and abroad at some of the world’s most renowned hospitals, including SUNY at Buffalo (New York) and WNY Healthcare System (Virginia) where he was the Chief of Vascular Surgery. Prior to joining Surgical Specialists of Ocala, Dr. Lall was Director of Vascular Surgery at Caribbean Heart Care and attending endovascular surgeon at Southern Medical Center in Trinidad and Tobago.

A well-rounded physician, Dr. Lall practiced general surgery and obstetrics and gynecology before discovering his passion for vascular surgery. Special clinical interests include: carotid surgery and stenting; open and endovascular aortic reconstruction –including fenestrated aortic stent grafts; complex visceral revascularization; venous surgery including endovenous ablation; SVC/ IVC reconstruction and management of hemodialysis patients.

Dr. Lall continues to author publications, presentations and abstracts, and has received numerous accolades and awards, including:

  • 2007   Fellow Teacher of the Year- Department of General Surgery,
    Mayo Clinic Rochester
  • 2004   Best Clinical Sciences Paper at Annual Camishon Research Day, Cooper University Hospital
  • 2006   Sigvaris Traveling Fellowship Award
    American Venous Forum
  • 1998   Best candidate at The University of Hull (UK) FRCS Course
  • 1994   Clinical Sciences in Medicine – University of the West Indies Honors: Obstetrics and Gynecology
  • 1992   Basic Sciences in Medicine – University of the West Indies
    Distinction: Pharmacology
    Honors: Anatomy, Physiology, and Biochemistry
  • 1988   National Scholarship- Government of Trinidad and Tobago

Dr. Lall is active in the medical community, participating in a number of professional membership societies, including:

  • American College of Surgeons- Fellow
  • Midwest Vascular Society- Associate Member
  • American Medical Association- Member
  • Trinidad and Tobago Medical Association- Member
  • American Venous Forum- Member
  • Society for Vascular Surgery- Member

Dr. Lall received his Fellowship of the Royal College of Surgeons of Edinburgh (FRCS) Ed in 1999 and has earned two certifications from the American Board of Surgery: General Surgery (2006) and Vascular Surgery (2007).

Looking for a friendly and highly qualified vascular surgeon? Dr. Lall would love to meet you. Call to schedule an appointment with him today.

Vein Center at NYU Langone First Academic Institution to Receive National Vein Center Accreditation

Recognition Demonstrates Commitment to Quality Vein Care For Those with Vein Disorders

NEW YORK, June 10, 2014 – The Vein Center at NYU Langone Medical Center announced that it is the first academic medical center to receive official vein center accreditation from the InterSocietal Accreditation Commission (IAC). The accreditation recognizes NYU Langone’s commitment to success in providing quality evaluation, care, and treatment for patients with vein disorders, which affect more than 50 percent of people over the age of 50.

“At NYU Langone’s Vein Center, we are committed to providing the highest level of care for our patients who suffer from venous disorders,” said Lowell S. Kabnick, MD, associate professor and director of the Vein Center at NYU Langone. “This recognition truly supports our goal of achieving the best patient outcomes through the use of advanced treatments and innovative techniques to manage and treat vein diseases individually in each patient.”

IAC Vein Center Accreditation is designed to accredit top facilities that perform evaluation and management of superficial venous disorders including sclerotherapy, ambulatory phlebectomy, venous ablation, and wound care. Accreditation is granted only to facilities providing quality patient care, as assessed by a panel of experts, in compliance with the IAC Vein Center Standards, which is an effective and established model for ensuring patient safety and minimal standards of care. The accreditation program is supported by national medical societies related to vein disorders which each serve as sponsoring organizations, including The American College of Surgeons (ACS); Society for Clinical Vascular Surgery (SCVS), and Society of Interventional Radiology (SIR).

According to the Vascular Disease Foundation, nearly 25 million people suffer from vein disorders, which can include varicose veins, reticular veins, spider veins, and venous leg ulcers. These conditions are often hereditary although hormonal factors such as puberty, pregnancy, and menopause, and the use of birth control pills also affect veins. However, with proper evaluation and treatment which can include a combination of medication or surgery, patients are able to reduce pain, increase blood flow through the entire body, and enhance external appearance.

About the Vein Center at NYU Langone Medical Center

The Vein Center at NYU Langone Medical Center is a recognized leader in vascular care not only in New York City, but in the world. Their comprehensive programs bridge the gap between the laboratory and the clinic, leading to top-quality patient care informed by world-renowned research programs. Part of the NYU Division of Vascular and Endovascular Surgery, the Vein Center is comprised of experienced surgeons, physicians and medical staff who focus on minimally invasive approaches to the diagnosis and treatment of varicose veins and other venous disorders. For more information, please visit NYU Langone’s Vein Center page or call 212-263-VEIN (8346).